NASDAQ:CRON Cronos Group (CRON) Stock Price, News & Analysis $2.14 -0.03 (-1.38%) (As of 09/6/2024 ET) Add Compare Share Share Today's Range$2.10▼$2.1850-Day Range$2.14▼$2.4952-Week Range$1.70▼$3.14Volume1.32 million shsAverage Volume2.19 million shsMarket Capitalization$818.08 millionP/E RatioN/ADividend YieldN/APrice Target$3.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Get Cronos Group alerts: Email Address Cronos Group MarketRank™ Stock AnalysisAnalyst RatingSell1.00 Rating ScoreUpside/Downside40.2% Upside$3.00 Price TargetShort InterestBearish2.68% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment1.13Based on 2 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($0.03) to $0.02 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.0.83 out of 5 starsMedical Sector807th out of 910 stocksMedicinals & Botanicals Industry10th out of 12 stocks 2.5 Analyst's Opinion Consensus RatingCronos Group has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no buy ratings, no hold ratings, and 1 sell rating.Amount of Analyst CoverageCronos Group has received no research coverage in the past 90 days.Read more about Cronos Group's stock forecast and price target. Previous Next 2.0 Short Interest Percentage of Shares Shorted2.68% of the float of Cronos Group has been sold short.Short Interest Ratio / Days to CoverCronos Group has a short interest ratio ("days to cover") of 5.3.Change versus previous monthShort interest in Cronos Group has recently increased by 3.47%, indicating that investor sentiment is decreasing. Previous Next 0.0 Dividend Strength Dividend YieldCronos Group does not currently pay a dividend.Dividend GrowthCronos Group does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for CRON. Previous Next 2.3 News and Social Media Coverage News SentimentCronos Group has a news sentiment score of 1.13. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.55 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Cronos Group this week, compared to 3 articles on an average week.Search InterestOnly 4 people have searched for CRON on MarketBeat in the last 30 days. This is a decrease of -71% compared to the previous 30 days.MarketBeat FollowsOnly 2 people have added Cronos Group to their MarketBeat watchlist in the last 30 days. This is a decrease of -71% compared to the previous 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Cronos Group insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 6.90% of the stock of Cronos Group is held by insiders.Percentage Held by InstitutionsOnly 8.71% of the stock of Cronos Group is held by institutions.Read more about Cronos Group's insider trading history. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for Cronos Group are expected to grow in the coming year, from ($0.03) to $0.02 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Cronos Group is -14.27, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Cronos Group is -14.27, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioCronos Group has a P/B Ratio of 0.75. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Cronos Group's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Timothy SykesTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT about Trump or Biden dropping out of the race…Click here to see a unique election-year trade About Cronos Group Stock (NASDAQ:CRON)Cronos Group Inc. operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.Read More CRON Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CRON Stock News HeadlinesAugust 27, 2024 | fool.comWhy Cronos Group Stock Is Sinking TodayAugust 20, 2024 | seekingalpha.comBuy Cronos Stock Before It Surges HigherSeptember 7, 2024 | Timothy Sykes (Ad)Tim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT about Trump or Biden dropping out of the race…August 17, 2024 | ca.finance.yahoo.comCRON Sep 2024 3.500 callAugust 17, 2024 | ca.finance.yahoo.comCRON Sep 2024 2.000 putAugust 15, 2024 | investorplace.com7 Growth Stocks to Buy on Corrections for 3X Returns by 2026August 9, 2024 | investorplace.com3 Cannabis Stocks That Can Be Massive Wealth Creators by 2030August 8, 2024 | fool.comWhy Investors Were High on Cronos Group TodaySeptember 7, 2024 | Timothy Sykes (Ad)Tim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT about Trump or Biden dropping out of the race…August 8, 2024 | globenewswire.comCronos Group Reports 2024 Second Quarter ResultsAugust 8, 2024 | investorplace.com7 Growth Stocks That Could 7X in the Next 7 YearsAugust 6, 2024 | investorplace.com3 Cannabis Stocks to Sell in August Before They Crash & BurnAugust 4, 2024 | ca.finance.yahoo.comCRON Aug 2024 1.000 callAugust 3, 2024 | detroitnews.comShort-seller Andrew Left’s deleted tweets reappear in fraud caseAugust 2, 2024 | investorplace.comWhat Are the Hottest Cannabis Stocks Right Now? 3 Top Picks.July 25, 2024 | globenewswire.comCronos Group Inc. to Hold 2024 Second Quarter Earnings Conference Call on August 8, 2024July 24, 2024 | benzinga.comLatest Cannabis Hires And Board Changes, Here's What You Need To KnowJuly 22, 2024 | benzinga.comCannabis Stocks React To Biden Announcement: Monday's Closing Market MovesSee More Headlines Receive CRON Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cronos Group and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/08/2024Today9/07/2024Next Earnings (Estimated)11/13/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Medicinals & botanicals Sub-IndustryPharmaceutical Products Current SymbolNASDAQ:CRON CUSIPN/A CIK1656472 Webwww.thecronosgroup.com Phone(416) 504-0004FaxN/AEmployees450Year FoundedN/APrice Target and Rating Average Stock Price Target$3.00 High Stock Price Target$3.50 Low Stock Price Target$2.50 Potential Upside/Downside+40.2%Consensus RatingSell Rating Score (0-4)1.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($0.15) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-73,960,000.00 Net Margins-56.43% Pretax Margin-61.24% Return on Equity-2.06% Return on Assets-1.99% Debt Debt-to-Equity RatioN/A Current Ratio28.29 Quick Ratio27.41 Sales & Book Value Annual Sales$101.78 million Price / Sales8.04 Cash FlowN/A Price / Cash FlowN/A Book Value$2.87 per share Price / Book0.75Miscellaneous Outstanding Shares382,281,000Free Float355,904,000Market Cap$818.08 million OptionableOptionable Beta0.97 7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed InvestorsAs the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.Get This Free Report Key ExecutivesMr. James Andrew McGinness III (Age 45)VP, Controller & Principal Accounting Officer Mr. Shayne J. LaidlawDirector of Investor Relations & StrategyMr. Adam Wagner (Age 41)Senior VP & Head of Cronos Israel Key CompetitorsIDEAYA BiosciencesNASDAQ:IDYAHUTCHMEDNASDAQ:HCMIovance BiotherapeuticsNASDAQ:IOVAXenon PharmaceuticalsNASDAQ:XENESpringWorks TherapeuticsNASDAQ:SWTXView All CompetitorsInstitutional OwnershipMackenzie Financial CorpBought 1,387,906 shares on 8/15/2024Ownership: 0.363%DRW Securities LLCSold 332,600 shares on 8/14/2024Ownership: 0.000%Cedar Wealth Management LLCBought 15,000 shares on 8/13/2024Ownership: 0.010%Renaissance Technologies LLCBought 127,753 shares on 8/9/2024Ownership: 0.122%WINTON GROUP LtdBought 127,235 shares on 8/9/2024Ownership: 0.033%View All Institutional Transactions CRON Stock Analysis - Frequently Asked Questions How have CRON shares performed this year? Cronos Group's stock was trading at $2.09 at the start of the year. Since then, CRON shares have increased by 2.4% and is now trading at $2.14. View the best growth stocks for 2024 here. How were Cronos Group's earnings last quarter? Cronos Group Inc. (NASDAQ:CRON) posted its earnings results on Thursday, August, 8th. The company reported ($0.02) EPS for the quarter. The company earned $27.76 million during the quarter, compared to the consensus estimate of $25.85 million. Cronos Group had a negative trailing twelve-month return on equity of 2.06% and a negative net margin of 56.43%. Who are Cronos Group's major shareholders? Cronos Group's top institutional investors include Dimensional Fund Advisors LP (0.69%), Mackenzie Financial Corp (0.36%), AdvisorShares Investments LLC (0.23%) and Renaissance Technologies LLC (0.12%). View institutional ownership trends. How do I buy shares of Cronos Group? Shares of CRON stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Cronos Group own? Based on aggregate information from My MarketBeat watchlists, some other companies that Cronos Group investors own include Tilray (TLRY), NVIDIA (NVDA), Advanced Micro Devices (AMD) and Dollar Tree (DLTR). This page (NASDAQ:CRON) was last updated on 9/7/2024 by MarketBeat.com Staff From Our PartnersPerfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying wit...Crypto 101 Media | SponsoredThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredTrump’s weapon lurks in abandoned AmericaUnemployment is sky-high, wages are at record lows. Addiction has overwhelmed these once thriving coal towns. ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cronos Group Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cronos Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CRON Stock Alerts